Janssen
Janssen and Partners Discontinue Mosaico HIV Vaccine Trial
The phase 3 Mosaico HIV vaccine clinical trial was discontinued because evidence of efficacy was lacking, according ...
JANUARY 19, 2023
FDA Limits Authorization of J&J/Janssen COVID-19 Vaccine Due to TTS Risk
The use of the Janssen COVID-19 vaccine has been restricted by the FDA to only people 18 years old and up who are ...
MAY 10, 2022
FDA Grants New Indication for Cabenuva for Every-8–Week Dosing
The FDA extended the time between shots of Cabenuva to every two months to treat HIV-1 infection in virologically ...
FEBRUARY 1, 2022
FDA Advisory Committee Votes on J&J COVID-19 Vaccine Booster Request
The company asks for an unusual caveat: The need for a booster would depend on the local/epidemiological situations ...
OCTOBER 15, 2021
ViiV Healthcare Submits NDA for the First Monthly, Injectable HIV Therapy
ViiV Healthcare is seeking approval for the investigational, monthly, injectable two-drug regimen ...
MAY 1, 2019
Symtuza Achieves Undetectable Viral Load Through 48 Weeks
Most HIV patients achieved an undetectable viral load through 48 weeks after starting the Symtuza (Janssen) ...
APRIL 16, 2019
Switching to a D/C/F/TAF Regimen
Gregory D. Huhn, MD, discusses an analysis of 48-week data from the EMERALD trial in subgroups based on age, gender ...
MAY 30, 2018
Single-Tablet Combo as Effective as Current HIV Treatment
If approved in the U.S., D/C/F/TAF would be the only complete regimen that could deliver the potential adherence ...
OCTOBER 11, 2017
New Injectable ART May Increase Effectiveness, Adherence Over Standard Oral Therapy
Intramuscular ART that can be given every four or eight weeks appears to be as effective as current oral ...
AUGUST 22, 2017
Once-Daily, Single-Tablet Regimen Suppressed HIV
AIDS Society Conference on HIV: A once-daily, single-tablet regimen (STR) containing Prezista, Tybost, Emtriva and ...
AUGUST 1, 2017
FDA Issues Warning Regarding Risk for Amputations With Diabetes Drug
The FDA issued a boxed warning for canagliflozin because it can increase the risk for leg and foot amputations.
MAY 23, 2017
2-Drug Combination Effective in Maintaining Viral Suppression in HIV Patients
The requirement of lifelong treatment for HIV infection has highlighted a need to minimize cumulative drug ...
FEBRUARY 17, 2017
